Hua Xue^1*, Yan Su^1*, Jianmei Xu^1*, Jiangbo Zhang^1*, Songying Zhao^1*, Jing Wang^1*, Huimei Guo^1*, Jia Liu^1* and Yao Liu²

¹Affiliated Hospital of Hebei University, Baoding, China
²Chongqing University Cancer Hospital, Chongqing, China

Carlyn Rose Tan, MD¹, Lucio Gordan^2*, Rachel Dileo^3*, Prerna Mewawalla^3*, Sarah M. Larson, MD⁴, Faith E Davies, MD⁵, David Oveisi, MD^6*, Niodita Gupta-Werner^7*, Rohan Medhekar^7*, Annelore Cortoos, MD^7*, Marjohn Armoon, PharmD^8*, Alvi Rahman^9*, Claire Vanden Eynde^9*, Marie-Hélène Lafeuille, MA^9*, John Reitan^10*, Gary Milkovitch^10*, Joseph Bubalo^11*, Adam Forman^12*, Douglas W Sborov, MD¹³, Shuchita Kaila⁷ and Saad Z. Usmani, MD¹⁴

¹Memorial Sloan Kettering Cancer Center, New York, NY
²Florida Cancer Specialists & Research Institute, Tampa, FL
³Division of Hematology and Cellular Therapy, Allegheny Health Network Cancer Institute, Pittsburgh, PA
⁴UCLA Health, Los Angeles, CA
⁵NYU Perlmutter Cancer Center, NYU Grossman School of Medicine, New York, NY
⁶Cedars-Sinai Medical Center, Los Angeles, CA
⁷Janssen Scientific Affairs, LLC, Horsham, PA
⁸Medical Director, Multiple Myeloma, Hematology US Medical Affairs, Janssen Scientific Affairs, LLC, Horsham, PA
⁹Analysis Group, Montreal, Canada
¹⁰RJM Group, LLC, Crown Point, IN
¹¹Oregon Health and Science University Knight Cancer Institute, Portland, OR
¹²Ascension Providence Hospital, Southfield, MI
¹³Huntsman Cancer Institute, University of Utah, Salt Lake City, UT
¹⁴Myeloma Service, Division of Hematologic Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY

Feng Lin^1*, Samy Gallienne^2*, Raluca Ionescu-Ittu^2*, Medha Sasane^1*, Ani Minasyan^1*, Christina Tekle^1* and Joshua Richter, MD³

¹Sanofi, Cambridge, MA
²STATLOG, Montreal, Canada
³Mount Sinai, New York, NY

Kathy Annunziata^1*, Nikoletta Sternbach^1*, Hitomi Tanaka^2*, Marco DiBonaventura^2*, Joseph C. Cappelleri, PhD^3*, Jack Watkins^2*, David Hughes, PharmD, BCOP^4*, Aster Meche^2*, Chai Hyun Kim^2*, C. Todd Kennedy^5*, Hans Scheurer^6* and Thomas W. LeBlanc, MD, MA, MS⁷

¹Oracle Life Sciences, Austin, TX
²Pfizer Inc, New York, NY
³Pfizer Inc, Groton, CT
⁴Pfizer Inc, Cambridge, MA
⁵Independent Patient and Research Advocate, Coto de Caza, CA
⁶Myeloma Patients Europe AISBL, Brussels, Belgium
⁷Duke Cancer Institute, Hillsborough, NC

Jocelyn R Wang^1*, Jennifer Hayden^1*, Yiyang Yue^1*, Craig S Meyer^1*, Ryan W Gan^1*, Youyi Zhang^1*, Benjamin Ackerman^1*, Pranay Mohanty^1*, James Roose^2*, Jennifer L Lund^3*, Sebastian Schneeweiss^4*, Janick Weberpals^4*, Omar Nadeem, MD⁵, Sikander Ailawadhi, MD⁶, Noopur Raje⁷, Smith Giri^8*, Juned Siddique^9*, Laura Hester^10*, Kelly Reid^1*, Robin Carson, MD¹¹, Khaled Sarsour, PhD, MPH^1* and Ashita Batavia, MD, MSc^1*

¹Janssen Research & Development, LLC, Titusville, NJ
²Flatiron Health, New York, NY
³Department of Epidemiology, University of North Carolina, Chapel Hill, Chapel Hill, NC
⁴Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA
⁵Center for Early Detection and Interception of Blood Cancers, Dana-Farber Cancer Institute, Boston, MA
⁶Division of Hematology-Oncology, Mayo Clinic, Jacksonville, FL
⁷Massachusetts General Hospital, Boston, MA
⁸University of Alabama at Birmingham, Birmingham, AL
⁹Feinberg School of Medicine, Northwestern University, Chicago, IL
¹⁰Janssen Research & Development, LLC, Horsham, PA
¹¹Janssen Research & Development, LLC, Spring House, PA

Christen M. Dillard, MD¹, Ashwath Gurumurthi, MBBS^2*, Hans C. Lee, MD², Sheeba K. Thomas, MD², Donna M. Weber, MD², Robert Z. Orlowski, MD, PhD², Muzaffar H. Qazilbash, MD³, Krina K. Patel, MD, MSc² and Michelle A.T. Hildebrandt, PhD²

¹Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
²Department of Lymphoma & Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
³Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX

Rahul Banerjee, MD, FACP¹, Alicia Richards, PhD^2*, Jack Khouri, MD³, Murali Janakiram, MBBS⁴, Kara I. Cicero, MD, MPH^5,6, Danai Dima, MD^3,6,7, Mehmet H. Kocoglu, MD⁸, Leyla O. Shune, MD⁹, Evguenia Ouchveridze, MD⁹, Tania Jain, MD¹⁰, Aimaz Afrough, MD¹¹, Saurabh Zanwar, MD, MBBS¹², Christopher Ferreri, MD¹³, Oren Pasvolsky, MD¹⁴, Lekha Mikkilineni, MD, MA¹⁵, Sneha Purvey, MD¹⁶, Lauren C. Peres, PhD, MPH^2*, Ciara Louise Freeman, PhD, MSc, FRCPC, MRCP¹⁷, Shonali Midha, MD^18*, Amer Beitinjaneh, MD^19*, James A Davis, PharmD^20*, Charlotte B Wagner, PharmD^21*, Megan M Herr, PhD²², Peter A. Forsberg, MD²³, Douglas W. Sborov, MD, MS²⁴, Shambavi Richard, MD²⁵, Ran Reshef, MD, MSc²⁶, Binod Dhakal, MBBS²⁷, Veronika Bachanova, MD, PhD²⁸, Joseph P. McGuirk, DO²⁹, Peter M. Voorhees, MD³⁰, Larry D Anderson Jr., MD, PhD³¹, Yi Lin, MD, PhD¹², Thomas G. Martin, MD³², Surbhi Sidana, MD³³, Krina K. Patel, MD, MSc³⁴, Doris K. Hansen, MD³⁵, Andrew J. Cowan, MD^5,6 and Gurbakhash Kaur, MD, MA³⁶

¹University of Washington Fred Hutchinson Cancer Center, Seattle, WA
²Department of Cancer Epidemiology, Moffitt Cancer Center, Tampa, FL
³Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
⁴Judy and Bernard Briskin Center for Multiple Myeloma Research, City of Hope, Duarte, CA
⁵Fred Hutchinson Cancer Center, Seattle, WA
⁶University of Washington, Seattle, WA
⁷Department of Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH
⁸University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center, Baltimore, MD
⁹University of Kansas Medical Center, Kansas City, KS
¹⁰Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD
¹¹Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Coppell, TX
¹²Division of Hematology, Mayo Clinic, Rochester, MN
¹³Atrium Health Levine Cancer Institute, Charlotte, NC
¹⁴Department of Lymphoma & Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
¹⁵Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Palo Alto, CA
¹⁶Virginia Commonwealth University, Richmond, VA
¹⁷Department of Blood and Marrow Transplantation and Cellular Immunotherapy, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
¹⁸Division of Hematologic Neoplasia, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA
¹⁹University of Miami, Miami, FL
²⁰Division of Hematology-Oncology, Medical University of South Carolina, Charleston, SC
²¹Division of Hematology and Hematologic Malignancies, Huntsman Cancer Institute at the University of Utah, Salt Lake City, UT
²²Department of Medicine (Transplant & Cellular Therapy Center), Roswell Park Comprehensive Cancer Center, Buffalo, NY
²³University of Colorado, Aurora, CO
²⁴Huntsman Cancer Institute, University of Utah, Salt Lake City, UT
²⁵Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY
²⁶Columbia Center for Translational Immunology, Columbia University Irving Medical Center, New York, NY
²⁷Division of Hematology and Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI
²⁸Division of Hematology, Oncology, and Transplantation, Department of Medicine, University of Minnesota, Minneapolis, MN
²⁹Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS
³⁰Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute, Atrium Health, Charlotte, NC
³¹Harold C. Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, TX
³²Department of Hematology, University of California at San Francisco, San Francisco, CA
³³Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, CA
³⁴M.D. Anderson Cancer Center, MD Anderson Cancer Center, Houston, TX
³⁵H. Lee Moffitt Cancer Center & Research Institute, Tampa
³⁶Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX

Emelly Rusli, MPH^1*, Aaron Galaznik, MD² and Debra Wujcik, PhD, RN^3*

¹Carevive by HealthCatalyst, Newton, MA
²Carevive by HealthCatalyst, Boston, MA
³Carevive by HealthCatalyst, Columbia, TN

Apoorva Doshi, MBBS^1*, Gayathri Ravi, MD², Kelly Godby^3*, Susan Bal, MD², Victoria Badia, MD^4*, Luciano J. Costa, MD, PhD², Grant Williams, MD^2*, Smita Bhatia, MD, MPH³ and Smith Giri^3*

¹Institute for Cancer Outcomes and Survivorship, University of Alabama at Birmingham, Birmingham, AL
²Division of Hematology and Oncology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL
³University of Alabama at Birmingham, Birmingham, AL
⁴Internal Medicine, University of Alabama at Birmingham, Birmingham, AL

Shivani Modi^1*, Charishma Bhimineni, DO^1* and Mitchell Goldstein, MD²

¹Jefferson Einstein Healthcare Network, Norristown, PA
²Jefferson Einstein Healthcare Network, Philadelphia, PA

Semegne Hiruy, BS^1*, Myra Robinson^2*, Shebli Atrash, MD³, Barry Paul, MD, MS⁴, Reed Friend, MD⁵, Cindy Varga, MD^6*, Christopher J Ferreri, MD^4*, Mauricio Pineda-Roman^6*, Peter M. Voorhees, MD⁷ and Manisha Bhutani, MD⁴

¹Wake Forest School of Medicine, Winston Salem
²Department of Biostatistics and Data Sciences, Levine Cancer Institute, Charlotte, NC
³Department of Hematologic Oncology & Blood Disorders, Levine Cancer Institute, Atrium Health Wake Forest University School of Medicine, Charlotte, NC
⁴Department of Hematologic Oncology and Blood Disorders, Atrium Health Levine Cancer Institute, Charlotte, NC
⁵Levine Cancer Institute, Atrium Health Wake Forest University School of Medicine, Charlotte, NC
⁶Department of Hematologic Oncology & Blood Disorders, Atrium Health Levine Cancer Institute, Charlotte, NC
⁷Atrium Health Levine Cancer Institute, Charlotte, NC

Charis Charalampous^1*, Shaji Kumar, MD², Ricardo D. Parrondo, MD³, Saurabh Chhabra, MD⁴, Madhu Nagaraj, MBBS^2*, Mei Sheng Duh, MPH⁵, Priyanka J. Bobbili, ScD, MS^5*, Aolin Wang, PhD^5*, Jingyi Chen^6*, Manasi Mohan, MS^5*, Patrick Hlavacek^7*, Rickard Sandin^8*, Joseph C. Cappelleri, PhD^9*, David Hughes, PharmD, BCOP^10*, Guido Nador^11* and Marco DiBonaventura^7*

¹Division of Hematology, Mayo Clinic Rochester, Rochester, MN
²Division of Hematology, Mayo Clinic, Rochester, MN
³Division of Hematology-Oncology, Mayo Clinic-Florida, Jacksonville, FL
⁴Division of Hematology, Mayo Clinic, Phoenix, AZ
⁵Analysis Group, Inc., Boston, MA
⁶Analysis Group Inc, Boston, MA
⁷Pfizer Inc, New York, NY
⁸Pfizer AB, Stockholm, Sweden
⁹Pfizer Inc, Groton, CT
¹⁰Pfizer Inc, Cambridge, MA
¹¹Pfizer Ltd, Surrey, United Kingdom

Jayla Mondy^1*, Saurav Das, MD^2*, Dhaani Ailawadhi^3*, Yaw Adu^4* and Sikander Ailawadhi, MD⁵

¹University of Mississippi Medical Center School of Medicine, Jackson, MS
²Department of Internal Medicine, Griffin Hospital, Derby, CT
³Bolles Middle School, Jacksonville, FL
⁴Texas Tech University Health Sciences Center School of Medicine, Lubbock, TX
⁵Division of Hematology-Oncology, Mayo Clinic-Florida, Jacksonville, FL

Andrew J Portuguese, MD¹, Mahnoosh Taheri, MD^2*, Rahul Banerjee, MD, FACP³, Kara I. Cicero, MD, MPH³, Mary Kwok, MD^3*, Natalie Wuliji, DO^3*, Lorenzo Iovino, MD, PhD³, Alexandre V. Hirayama, MD⁴, Erik L Kimble, MD³, Leona Holmberg, MD, PhD⁵, Mazyar Shadman, MD, MPH⁶, Jordan Gauthier, MD, MSc³, David G. Maloney, MD, PhD⁷ and Andrew J. Cowan, MD³

¹University of Washington Fred Hutchinson Cancer Center, Seattle, WA
²Washington State University, Spokane, WA
³Fred Hutchinson Cancer Center, Seattle, WA
⁴Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA
⁵University of Washington, Seattle, WA
⁶Fred Hutchinson Cancer Research Center, Seattle, WA
⁷Fred Hutch Cancer Center, University of Washington, Seattle, WA

Jeries Kort, MD^1,2, James J Ignatz-Hoover, MD, PhD^1,3 and James J. Driscoll II, MD^1,2

¹Case Comprehensive Cancer Center, Cleveland, OH
²University Hospitals Seidman Cancer Center, Cleveland, OH
³Department of Medicine, Division of Hematology and Oncology, University Hospitals Seidman Cancer Center, Cleveland, OH

Edvan De Queiroz Crusoe, MD, PhD, MSc¹, Seisha Von Glasenapp, MEd², Glaciano Ribeiro, MD^3*, Leila Perobelli, MD^4*, Paola Ochoa, MD^5*, Fernando Vieira Pericole, MD, PhD^6*, Sergio Lopresti^7*, Jayr Schmidt Filho, MD^8*, Cesar Samanez^9*, Guillermina Remaggi, MD^10*, Emanuella Souza, MD^11*, Eloisa Riva, MD, MEd¹², Javiera PAZ Donoso Pineda, MD^13*, Pedro Manoel Marques Garibaldi^14*, Milton A. F. Aranha, MD^15*, Roberto Pessoa Magalhaes Filho, MD^16*, Aline Ramirez Alvarado, MD^17*, Dorotea Beatriz Eugenia Fantl, MD¹⁸, Kenny Galvez, MD^19*, Dani Laks, MD^20*, Jose Ramiro Espinoza Zamora, MD^21*, Juliana Lima, MD^22*, Rodrigo Ezequiel Vallejo, MD^23*, Camila Peña, MD²⁴ and Vania Hungria, MD, PhD²⁵

¹Hospital Universitário Professor Edgar Santos da Universidade Federal da Bahia (HUPES), Salvador, Bahia, Brazil
²Hospital Central Instituto de Previsión Social, Asuncion, Paraguay
³Clinica Hematologica, Belo Horizonte, BRA
⁴Hospital de Transplantes Euryclides de Jesus Zerbini / Hospital Brigadeiro, São Paulo, Brazil
⁵Instituto Alexander Fleming, Buenos Aires, Argentina
⁶Hemocentro -Unicamp, Campinas, Brazil
⁷Hospital Nacional Alejandro Posadas-Argentina, Buenos Aires, ARG
⁸AC Camargo Cancer Center, Sao Paulo, BRA
⁹AUNA PEru, LIMA, PER
¹⁰FUNDALEU, Buenos Aires, Argentina
¹¹Hospital de Clinicas da UFMG-Brazil, Belo Horizonte, BRA
¹²Hematology, Hospital de Clinicas, Montevideo, Uruguay
¹³Clínica Alemana de Santiago- Chile, SANTIAGO, CHL
¹⁴Hematology Division, Department of Medical Imaging, Hematology, and Clinical Oncology, Ribeirao Preto Medical School at University of Sao Paulo, Ribeirao Preto, Brazil, Ribeirão Preto, Brazil
¹⁵HEMOMED- BRAZIL, São Paulo, BRA
¹⁶Federal University of Rio de Janeiro, Rio de Janeiro, Brazil
¹⁷Centro Medico Nacional la Raza- Mexico, Mexico, MEX
¹⁸Hospital Italiano de Buenos Aires, Buenos Aires, Argentina
¹⁹Hospital Pablo Tobón Uribe, Medellín, Colombia
²⁰Hospital Moinhos de Vento-Brazil, Porto Alegre, BRA
²¹Instituto Nacional de Cancerologia, Mexico City, Mexico
²²Oncoclínicas Curitiba- Brazil, Curitiba, Brazil
²³Hospital Español de Buenos Aires- Argentina, BUENOS AIRES, Argentina
²⁴Hospital Del Salvador, Santiago, Chile
²⁵Clinica São Germano, São Paulo, Brazil

Poy Theprungsirikul, MD¹, Rong Wang, PhD^2*, Man-Yee Merl, PharmD, BCOP^3*, Shi-Yi Wang, MD, PhD^2* and Natalia Neparidze, MD¹

¹Department of Internal Medicine, Section of Hematology, Yale School of Medicine and Yale Cancer Center, New Haven, CT
²Department of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, CT
³Yale Cancer Center, Yale New Haven Hospital, New Haven, CT

Aishwarya Anuraj, MBBS^1*, Divya Rath, BS^2*, Andriy Derkach, PhD^3*, Saad Z. Usmani, MD^4,5 and Urvi A. Shah, MD^4,5

¹Department of Medicine, Myeloma Service, Memorial Sloan Kettering Cancer Center, Princeton, NJ
²College of Medicine, Howard University, Washington, DC
³Department of Biostatistics and Epidemiology, Memorial Sloan Kettering Cancer Center, New York, NY
⁴Myeloma Service, Division of Hematologic Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
⁵Department of Medicine, Weill Cornell Medical College, New York, NY

Dor Shpitzer, BSc^1*, Yael C. Cohen, MD^2,3*, Tamir Shragai, MD^2,3*, Guy Melamed^4*, Anat Reiner-Benaim, PhD^5* and Irit Avivi Mazza^3,6*

¹Faculty of Medicine, Ben Gurion University of the Negev, Tel Aviv, NY, Israel
²Department of Hematology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel
³Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
⁴Kahn Sagol Maccabi Research & Innovation Center, Maccabi Healthcare Services, T, Tel-Aviv, Israel
⁵Department of Epidemiology, Biostatistics and Community Health Sciences, School of Public Health, Faculty of Health Sciences, Ben Gurion University of the Negev, Beer Sheva, Israel, Beer Sheva, ISR
⁶Hematology Division, Sourasky Medical Center and the Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel

Sarah Lawton, MPH^1*, Mark J Bishton, PhD, MBChB^2,3, Peter Clark, MA MD FRCP^4*, Katherine Thackray, DPhil^1* and Dean Smith, BA(Hons) MBBS MRCP FRCPath MD(Res)^2,3*

¹National Disease Registration Service, NHS England, London, United Kingdom
²Clinical Haematology, Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom
³School of Medicine, University of Nottingham, Nottingham, United Kingdom
⁴NHS England, London, United Kingdom

Luca Paruzzo, MD^1,2,3*, Khashayar Eshaghi^4*, Guido Ghilardi, MD^1,2,5*, Abigail Doucette^6*, Adam Waxman, MD^3,7*, Adam D. Cohen, MD^3,7, Dan T. Vogl, MD, MS^3,7, Shivani Kapur, MD^3,7, Eugenio Fardella, MD^2,8*, Alberto Carturan^1,2*, Luke Maillie^9*, Sofia Kaparis^9*, Jalpa A. Doshi, PhD^9*, Alfred L. Garfall, MD^3,7, Edward A. Stadtmauer, MD^3,7, Carmen E Guerra, MD^9*, Sandra Susanibar-Adaniya, MD^3,7 and Marco Ruella, MD^1,2,3,4,7

¹Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA
²Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA
³Division of Hematology/Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA
⁴Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA
⁵Ente Ospedaliero Cantonale, Bellinzona, Switzerland
⁶Department of Biostatistics, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA
⁷Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA
⁸Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
⁹Department of Medicine, Hospital of the University of Pennsylvania, Division of General Medicine, Philadelphia, PA

Lilly Gu, MD^1*, Nisha S. Joseph, MD², Vikas A. Gupta, MD, PhD², Craig C. Hofmeister, MD², Madhav V. Dhodapkar, MD PhD², Sagar Lonial, MD^3*, Ajay K. Nooka, MD, MPH⁴ and Jonathan L. Kaufman, MD²

¹Emory University, Atlanta
²Winship Cancer Institute of Emory University, Atlanta, GA
³Winship Cancer Institute, Atlanta, GA
⁴Winship Cancer Institute of Emory University, Atlanta

Metodi Balev, MD¹, Nishi Shah, MBBS, MPH², Mansi R. Shah, MD³, Anannya Patwari, MD^4*, Aniko Szabo, PhD^4*, Anita D'Souza, MD⁵, Asis Shrestha, MD^6*, Binod Dhakal, MBBS⁷, Danny Luan, MD, MPH⁸, Dennis L Cooper, MD², Frits van Rhee, MD, PhD⁶, Heloise Cheruvalath⁴, Jorge Monge, MD⁹, Mark Forsberg, MD^2*, Maurizio Zangari, MD¹⁰, Sharmilan Thanendrarajan, MD⁶, Vineel Bhatlapenumarthi^4*, Samer Al-Hadidi, MD^6*, Suzanne Lentzsch, MD, PhD¹, Divaya Bhutani, MD¹, Rajshekhar Chakraborty, MD¹, Carolina Schinke, MD¹⁰ and Meera Mohan, MD¹¹

¹Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, NY
²Montefiore Einstein Comprehensive Cancer Center, Blood Cancer Institute, Department of Oncology, Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, NY
³Rutgers Cancer Institute of New Jersey, New Brunswick, NJ
⁴Medical College of Wisconsin, Milwaukee, WI
⁵Center for International Blood and Marrow Transplant Research, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI
⁶University of Arkansas for Medical Sciences, Little Rock, AR
⁷Division of Hematology and Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI
⁸New York-Presbyterian Hospital/Weill Cornell Medicine, Astoria, NY
⁹New York-Presbyterian Hospital/Weill Cornell Medicine, New York, NY
¹⁰Myeloma Center, Winthrop P. Rockefeller Cancer Institute, University of Arkansas for Medical Sciences, Little Rock, AR
¹¹Division of Hematology and Oncology, Medical College of Wisconsin, Milwaukee, WI

Maxim Soloviev, MD, PhD^1*, Larisa Mendeleeva, MD, PhD^2*, Maiia Soloveva, MD, PhD^2*, Tatiana Ianovna Pospelova, MD, PhD^3*, Natalia Skvortsova, MD, PhD^4*, Elena Volodicheva, MD, PhD^5*, Evgenia Zhelnova, MD, PhD^6*, Elena Kirillova, MD^7*, Marina Kiseleva, MD^8*, Alina Chuprakova, MD^9*, Varvara Bahtina, MD^10*, Galina Kuchma, MD, PhD^11*, Oksana Ochirova, MD^12*, Sergey Voloshin, MD, PhD^13*, Andrey Garifullin, MD^14*, Tatiana Mitina, MD, PhD^15*, Galina Dudina, MD, PhD^16*, Victoriya Abramova, MD^17*, Tatyana Olkhovik, MD^18*, Marina Zakharova, MD^19*, Ilya Usankin, MD^20*, Nadezhda Medvedeva, MD, PhD^21*, Viktoria Ryabchikova, MD, PhD^21*, Anastasiya Semenova, MD, PhD^22*, Anna Kopylova, MD^23*, Natalya Solovkova, MD^24*, Marina Demchenkova, MD, PhD^25*, Tatyana Tsyganok, MD^26*, Yulia Gammershmidt, MD^27* and Olesya Kuznetsova, MD^28*

¹National Medical Research Center for Hematology, Moscow, Russia
²National Medical Research Center for Hematology, Moscow, Russian Federation
³Medical State University, Novosibirsk, RUS
⁴Medical State University, Novosibirsk, Russian Federation
⁵Regional Clinical Hospital, Tula, Russian Federation
⁶City Clinical Hospital No. 52, Moscow, Russian Federation
⁷Regional Clinical Hospital, Omsk, Russian Federation
⁸Regional Clinical Hospital, Simferopol, Russian Federation
⁹Regional Clinical Hospital, Kaliningrad, RUS
¹⁰Regional Clinical Hospital, Krasnoyarsk, Russian Federation
¹¹Department of Faculty Therapy and Endocrinology, Orenburg State Medical University, Orenburg, Russian Federation
¹²Regional Clinical Hospital, Ulan-Ude, AL, RUS
¹³FMBA, Russian Scientific and Research Institute of Hematology and Transfusiology, St Petersburg, Russian Federation
¹⁴Russian Research Institute of Hematology and Transfusiology, Saint-Petersburg, Russian Federation
¹⁵Moscow Regional Scientific Research Clinical Institute named after. M. F. Vladimirsky, Moscow, Russian Federation
¹⁶Moscow Clinical Scientific Center named after A.S. Loginov, Moscow, Russian Federation
¹⁷Regional Clinical Hospital, Vladimir, Russian Federation
¹⁸Interdistrict Clinical Hospital №7, Krasnoyarsk, Russian Federation
¹⁹City Clinical Hospital №1, Chelyabinsk, Russian Federation
²⁰Central City Hospital №7, Yekaterinburg, Russian Federation
²¹City Clinical Hospital №31, Saint-Petersburg, Russian Federation
²²The Blokhin National Medical Research Center of Oncology of the Russian Ministry of Health, Moscow, RUS
²³Regional Oncology Dispensary, Lipetsk, Russian Federation
²⁴Regional Clinical Hospital, Irkutsk, Russian Federation
²⁵regional oncology clinic, Irkutsk, Russian Federation
²⁶Regional Clinical Hospital, Yuzhno-Sakhalinsk, Russian Federation
²⁷Regional Clinical Hospital, Tomsk, Russian Federation
²⁸City Clinical Hospital No. 29 named after A.A Lutsik, Novokuznetsk, Russian Federation

Brittany Grossi^1*, Nina Kim^2*, Monal Kohli^3*, Bingcao Wu^2*, Emeka Umeh^3*, Dee Lin^2*, Gideon Aweh^3*, Emily Achter^3*, Laura Hester^4*, Sian Walker^5*, Christina Hearty^2* and Peter M. Voorhees, MD⁶

¹Howard University College of Medicine, Washington, DC, Washington DC
²Janssen Scientific Affairs, LLC, Horsham, PA
³STATinMED LLC, Dallas, TX
⁴Janssen Research & Development, LLC, Horsham, PA
⁵Sierra Medical Affairs, LLC, Truckee, CA
⁶Atrium Health Levine Cancer Institute, Charlotte, NC

Ariel F. Grajales-Cruz, MD¹, Allison Graeter, MD², Doris K. Hansen, MD³, Omar Castaneda, MD³, Mariola A Vazquez-Martinez, MD⁴, Shrikar Modukuri^5*, Gabriel De Avila^1*, Ariel Denson, PharmD^6*, Julia Fadul, PharmD^7*, Katherine Tobon, PharmD, BS^8*, Brandon Blue¹, Blanca Lopez^5*, Kristy Harvey^7*, Parker Melnick, BS^7*, Shrinjaya B Thapa, MD⁹, Filip Ionescu, MD, MS⁵, Hien Liu, MD⁵, Jose L. Ochoa-Bayona, MD^5*, Ciara Louise Freeman, PhD, MSc, FRCPC, MRCP³, Frederick Locke, MD⁵, Taiga Nishihori, MD⁵, Kenneth H. Shain, MD, PhD¹⁰, Rachid Baz, MD⁵ and Melissa Alsina, MD⁵

¹H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
²University of South Florida, Tampa, FL
³Department of Blood and Marrow Transplantation and Cellular Immunotherapy, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
⁴H Lee Moffitt Cancer Center and Research Institute, Tampa, FL
⁵Moffitt Cancer Center, Tampa, FL
⁶Department of Pharmacy, Moffitt Cancer Center, Tampa, FL
⁷Moffitt Cancer Center, Tampa
⁸Department of Pharmacy, H Lee Moffitt Cancer Center and Research Institute, Tampa, FL
⁹Moffitt Cancer Center, Lutz, FL
¹⁰H. Lee Moffitt Cancer Center, Tampa, FL

Lauren C. Peres, PhD, MPH^1*, Alicia Richards, PhD^1*, Surbhi Sidana, MD², Laura B. Oswald, PhD^3*, Danai Dima, MD⁴, Aimaz Afrough, MD⁵, Leyla O. Shune, MD⁶, Shonali Midha, MD^7*, Omar Castaneda, MD⁸, Christopher Ferreri⁹, James A Davis, PharmD^10*, Oren Pasvolsky, MD¹¹, Christen M. Dillard, MD¹², Megan M Herr, PhD¹³, Mehmet H. Kocoglu, MD¹⁴, Shebli Atrash, MD, MS⁹, Brandon Blue¹⁵, Evguenia Ouchveridze, MD¹⁶, Joseph P. McGuirk, DO¹⁷, Charlotte B Wagner, PharmD^18*, Radhika Bansal, MBBS^19*, Patrick Costello, MS^7*, Kinaya Smith, MD^20*, Alex Lieberman-Cribbin^21*, Gabriel De Avila^15*, Sneha Purvey, MD²², Hitomi Hosoya, MD, PhD²³, Lekha Mikkilineni, MD, MA²³, Gurbakhash Kaur, MD, MA²⁴, Mahmoud R. Gaballa, MD²⁵, Peter A. Forsberg, MD²⁶, Ciara Louise Freeman, PhD, MSc, FRCPC, MRCP⁸, Murali Janakiram, MBBS²⁷, Myo Htut, MD²⁷, Sireesha Asoori, MBBS, MPH^28*, Nilesh Kalariya, PhD, RN^29*, Djordje Atanackovic, MD³⁰, Binod Dhakal, MBBS³¹, Jack Khouri, MD³², Shahzad Raza, MD⁴, Ran Reshef, MD, MSc³³, Melissa Alsina, MD³⁴, Frederick L. Locke, MD³⁵, Omar Nadeem, MD³⁶, Faiz Anwer, MD⁴, Larry D Anderson Jr., MD, PhD³⁷, Shambavi Richard, MD²¹, Yi Lin, MD, PhD³⁸, Thomas Martin, MD²⁸, Peter M. Voorhees, MD³⁹, Krina K. Patel, MD, MSc¹¹, Doris K. Hansen, MD⁸ and Douglas W Sborov, MD⁴⁰

¹Department of Cancer Epidemiology, Moffitt Cancer Center, Tampa, FL
²Stanford University School of Medicine, Stanford, CA
³Department of Health Outcomes and Behavior, Moffitt Cancer Center, Tampa, FL
⁴Department of Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH
⁵Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Coppell, TX
⁶Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas, Westwood, KS
⁷Dana-Farber Cancer Institute, Boston, MA
⁸Department of Blood and Marrow Transplantation and Cellular Immunotherapy, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
⁹Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute, Atrium Health, Charlotte, NC
¹⁰Division of Hematology-Oncology, Medical University of South Carolina, Charleston, SC
¹¹Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
¹²Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
¹³Roswell Park Comprehensive Cancer Center, Buffalo, NY
¹⁴University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center, Baltimore, MD
¹⁵H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
¹⁶University of Kansas Medical Center, Kansas City, KS
¹⁷Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Ctr., Westwood, KS
¹⁸Division of Hematology and Hematologic Malignancies, Huntsman Cancer Institute at the University of Utah, Salt Lake City, UT
¹⁹Division of Hematology, Mayo Clinic, Bismarck, ND
²⁰Medical College of Wisconsin, Milwaukee, WI
²¹Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY
²²Virginia Commonwealth University, Richmond, VA
²³Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Palo Alto, CA
²⁴Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX
²⁵The University of Texas MD Anderson Cancer Center, Houston, TX
²⁶University of Colorado Cancer Center, Denver, CO
²⁷Judy and Bernard Briskin Center for Multiple Myeloma Research, City of Hope, Duarte, CA
²⁸UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA
²⁹Department of Lymphoma & Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
³⁰University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD
³¹Division of Hematology and Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI
³²Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
³³Herbert Irving Comprehensive Cancer Center, Columbia University, New York, NY
³⁴Moffitt Cancer Center, Tampa, FL
³⁵Department of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL
³⁶Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA
³⁷Harold C. Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, TX
³⁸Division of Hematology, Mayo Clinic, Rochester, MN
³⁹Plasma Cell Disorders Section, Department of Hematologic Oncology & Blood Disorders, Levine Cancer Center, Charlotte, NC
⁴⁰Huntsman Cancer Institute, University of Utah, Salt Lake City, UT

Beth M. Faiman, PhD, CNP¹, Cesar Rodriguez, MD^2*, Smith Giri, MD, MHS^3*, Christine Brittle, PhD^4*, Jay R. Hydren, PhD⁵, Karla Mariana Castro Bórquez, MD^5*, Maria Gambill, BA^5*, Ana M. Sahagun Sanchez Aldana, MS^5*, Jennifer M. Ahlstrom, BA^5*, Hoa H. Le, PhD^6*, Saurabh N. Patel, MD^6*, Kathleen S Gray^6*, Xinke Zhang, PhD^6* and Rafael Fonseca, MD⁷

¹Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
²Division of Hematology-Oncology, Department of Internal Medicine, Mount Sinai, New York, NY
³Division of Hematology and Oncology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL
⁴CorEvitas, Waltham, MA
⁵HealthTree Foundation, Lehi, UT
⁶Johnson & Johnson Innovative Medicine, Horsham, PA
⁷Division of Hematology, Mayo Clinic, Paradise Valley, AZ

Anup Joseph Devasia, MD, DM^1*, Olsen Chan, BHSc(Honours)^2*, Harjot Vohra, MD, CCRP, MLT^1*, Esther Masih-Khan, PhD^1*, Chloe Yang, MD^1*, Sita Bhella, MD^3*, Rodger E Tiedemann, MBChB, PhD¹, Vishal Kukreti, MD, MSc⁴, Christine I Chen, MHPE, MD⁵, Keith Stewart, MB BCh, MBA^1*, Donna Reece, MD¹, Suzanne Trudel, MD, MSc¹ and Guido Lancman, MD, MSc¹

¹Princess Margaret Cancer Centre, Toronto, ON, Canada
²Temerty Faculty of Medicine, University of Toronto, Toronto, ON, Canada
³Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre - University Health Network, Toronto, ON, Canada
⁴Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada
⁵Princess Margaret Cancer Centre - University Health Network, Toronto, ON, Canada

Martin F Kaiser, MD¹, Saba Ul-Hasan, MSc^2*, Jack Lewis, MSci^2*, Federica Mirto, MA^2*, Alicia O'Neill, MA^3*, Elise Gamertsfelder, MSc^4* and Yelak Biru^5*

¹The Institute of Cancer Research, London, ENG, United Kingdom
²MedGeist, London, United Kingdom
³GSK plc, Collegeville, PA
⁴Eric Low Consulting, London, United Kingdom
⁵International Myeloma Foundation, Greater Los Angeles, CA

Bhavesh Mohan Lal, MD¹, Marah Alzubi^2*, Jawad Alrawabdeh^2*, John D Shaughnessy, Jr, PhD^3*, Fenghuang Zhan, MD⁴, Eric Siegel^5*, Carolina Schinke, MD⁴, Sharmilan Thanendrarajan, MD⁴, Maurizio Zangari, MD⁴, Frits van Rhee, MD, PhD⁶ and Samer Al Hadidi, MD, MSc⁶

¹University of Arkansas for Medical Sciences, Little Rock, Little Rock, AR
²University of Jordan, Amman, Jordan
³Myeloma Center, Winthrop P. Rockefeller Cancer Institute, University of Arkansas for Medical sciences, Little Rock, AR
⁴Myeloma Center, Winthrop P. Rockefeller Cancer Institute, University of Arkansas for Medical Sciences, Little Rock, AR
⁵Department of Biostatistics, University of Arkansas For Medical Sciences, Little Rock, AR
⁶University of Arkansas for Medical Sciences, Little Rock, AR

Firas Baidoun, MD^1*, Vivek Roy, MD¹, Ricardo D. Parrondo, MD¹, Andre Fernandez, P.A. -C^1*, Caitlin Flott^1*, Taimur Sher, MD^2*, Rami Manochakian, MD^1*, Asher A. Chanan-Khan, MD¹ and Sikander Ailawadhi, MD¹

¹Division of Hematology-Oncology, Mayo Clinic-Florida, Jacksonville, FL
²Division of Hematology, Mayo Clinic, Jacksonville, FL

Amna Gul, MD^1*, Yumna Afaq, MBBS^2*, Talha Khan, MBBS^3*, Mahnoor Asghar Keen, MD, MBBS^3*, Shayan Ahmad, MBBS^3*, Mahd Aftab Khan, MD^4*, Rida Hussain, MD^5*, Arslan Inayat, MD^6*, Danish Safi, MD⁷ and Salahuddin Safi, MD^8*

¹Miami Cancer Institute, Miami, FL
²Khyber Medical College, Peshawar
³Khyber Medical College, Peshawar, Pakistan
⁴West Virginia University, Morgantown, WV
⁵Camden Clark Medical Center, Parkersburg, WV
⁶HSHS St.Mary's Hospital, Decatur
⁷Department of Medical Oncology, West Virginia University Cancer Institute, Morgantown, WV
⁸West Virginia University Cancer Institute, Morgantown, WV

Yash Shah, MD^1*, Mark Fiala, PhD^2*, Keith Stockerl-Goldstein, MD³, Mark A. Schroeder, MD³, Ravi Vij, MD, MBA³, Zachary D. Crees, MD⁴ and Michael Slade, MD, MS³

¹Hematology and Oncology, Ochsner MD Anderson Cancer Center, New Orleans, LA
²Division of Oncology, Washington University School of Medicine, Saint Louis, MO
³Division of Oncology, Washington University School of Medicine, St. Louis, MO
⁴Division of Oncology, Washington University School of Medicine, Frontenac, MO

Selina J Chavda, MBBS, BSc, MRCP^1*, Marquita Camilleri, MD^2*, Andrew Hall^3*, Laura Clayton^3*, Fatjon Dekaj^1*, Dunsi Bolarinwa^1*, Chantelle Hughes^1*, Doina Levinte^4*, Eileen M Boyle, MBChB, PhD¹, Martin F Kaiser, MD⁵, Rachel O'Malley^6*, Emma Williams^7*, Andie Guy^8*, Pinkie Chambers^1*, Sandra CM Quinn, PhD, BA^9* and Rakesh Popat¹⁰

¹University College London Hospitals NHS Foundation Trust, London, United Kingdom
²Department of Haematology, Addenbrooke's Hospital, Cambridge, United Kingdom
³Cancer Research UK Clinical Trials Research Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, United Kingdom
⁴Cancer Research UK Clinical Trials Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, United Kingdom
⁵The Institute of Cancer Research, London, United Kingdom and the Royal Marsden Hospital, London, United Kingdom
⁶Blood Cancer UK, London, United Kingdom
⁷University Hospital of Wales, Cardiff, United Kingdom
⁸St Bartholomew's Hospital, Bart's NHS Trust, London, United Kingdom
⁹Research and Advocacy, Myeloma UK, Edinburgh, SCO, United Kingdom
¹⁰Department of Haematology, University College London Hospitals NHS Foundation Trust, London, United Kingdom

Yang Xu^1*, Xuzhao Zhang^2*, Luyao Wang^1*, Yili Fan^1*, Boxiao Chen^1*, Luyu Yang^1* and Jiawei Zhang^1*

¹the Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
²Department of Hematology, The Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China

Maximilian J. Steinhardt^1*, Christoph Schaefers, MD^2*, Lisa Leypoldt, MD^2*, Marie Harzer^2*, Xiang Zhou, MD, BMBS³, Christine Riedhammer, MD^4*, Abdulaziz Kamili, MD^2*, Ricardo Kosch, MD^2*, Jule Arztenroth, MD^2*, Maximilian Al-Bazaz, MD^2*, Winfried Alsdorf^5*, Max S. Topp^4*, Johannes Duell, MD^6*, Julia Mersi, MD^1*, Johannes Waldschmidt, MD⁷, Carsten Bokemeyer, MD^2*, Hermann Einsele, MD¹, K. Martin Kortüm, MD^8*, Katja C. Weisel, MD⁵ and Leo Rasche, MD^9,10*

¹Department of Internal Medicine II, University Hospital Würzburg, Würzburg, Germany
²University Medical Center Hamburg Eppendorf, Hamburg, Germany
³University Hospital Wuerzburg, Wurzburg, Germany
⁴University Hospital Wuerzburg, Wuerzburg, Germany
⁵University Medical Center Hamburg-Eppendorf, Hamburg, Germany
⁶University of Wurzburg, Wurzburg, Germany
⁷Department of Internal Medicine II, University Hospital Wuerzburg, Wuerzburg, Germany
⁸Department of Internal Medicine II, University Hospital of Würzburg, Wuerzburg, Germany
⁹Department of Internal Medicine, University Hospital of Würzburg, Würzburg, Germany
¹⁰Mildred-Scheel-Nachwuchszentrum, Wuerzburg, Germany

Shaji Kumar, MD¹, William A. Wood, MD, MPH², Kenneth C. Anderson, MD³, Emily A. Semmel, MS^4*, Shandra James^4*, Donna S. Neuberg, ScD⁵, Kathleen Hewitt, DNP, RN^6*, Mark A. Schroeder, MD⁷, David J. Chung, MD, PhD⁸, Aaron S. Rosenberg, MD⁹, Jeffrey A. Zonder, MD ¹⁰, Samuel M. Rubinstein, MD¹¹, Anita D'Souza, MD¹², Thomas Martin, MD¹³, Ajai Chari, MD¹⁴, Ravi Vij, MD, MBA⁷, Ajay K. Nooka, MD, MPH¹⁵, Manisha Bhutani, MD¹⁶, Peter M. Voorhees, MD¹⁷, Adam S. Sperling, MD, PhD¹⁸, Susan M. Geyer, PhD¹⁹, Michael W. Craige, PhD, MBA^4*, Sam Walters, MBA^20*, Andriy Derkach, PhD^21* and Saad Z. Usmani, MD²²

¹Division of Hematology, Mayo Clinic, Rochester, MN
²Division of Hematology/Oncology, Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC
³Dana-Farber/Boston Children's Cancer and Blood Disorders Ctr, Boston, MA
⁴ASH Research Collaborative, Washington, DC
⁵Department of Data Science, Dana-Farber Cancer Institute, Boston, MA
⁶ASH Research Collaborative, Gainesville, VA
⁷Division of Oncology, Washington University School of Medicine, St. Louis, MO
⁸Transplant and Cellular Therapy Services, Division of Hematologic Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
⁹UC Davis Comprehensive Cancer Center, Sacramento, CA
¹⁰Karmanos Cancer Institute, Detroit, MI
¹¹Division of Hematology, University of North Carolina School of Medicine, Chapel Hill, NC
¹²Center for International Blood and Marrow Transplant Research, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI
¹³Department of Hematology, University of California at San Francisco, San Francisco, CA
¹⁴University of California, San Francisco, San Francisco, CA
¹⁵Winship Cancer Institute of Emory University, Atlanta
¹⁶Atrium Health Levin Cancer Institute, Charlotte, NC
¹⁷Plasma Cell Disorders Section, Department of Hematologic Oncology & Blood Disorders, Levine Cancer Center, Charlotte, NC
¹⁸Dana-Farber Cancer Institute, Boston, MA
¹⁹Alliance Statistics and Data Management Center, Mayo Clinic, Rochester, MN
²⁰Breakthrough Healthcare, Baltimore, MD
²¹Department of Biostatistics and Epidemiology, Memorial Sloan Kettering Cancer Center, New York, NY
²²Myeloma Service, Division of Hematologic Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY

Edward R Scheffer Cliff, MBBS, MPH¹, Martin F Kaiser, MD², Douglas W. Sborov, MD, MS³, Rafael Fonseca, MD⁴ and Ghulam Rehman Mohyuddin, MD⁵

¹Peter MacCallum Cancer Centre, Parkville, Australia
²The Institute of Cancer Research, London, ENG, United Kingdom
³University of Utah School of Medicine, Salt Lake City, UT
⁴Division of Hematology, Mayo Clinic, Paradise Valley, AZ
⁵Huntsman Cancer Institute, University of Utah, Salt Lake City, UT

Rahul Banerjee, MD, FACP¹, Nina Kim^2*, Monal Kohli^3*, Emeka Umeh^3*, Dee Lin^2*, Gideon Aweh^3*, Jessica Fowler, PhD^2*, Emily Achter^3*, Laura Hester^4*, Sian Walker^5*, Christina Hearty^2* and Bingcao Wu^2*

¹Fred Hutchinson Cancer Center, Seattle, WA
²Janssen Scientific Affairs, LLC, Horsham, PA
³STATinMED LLC, Dallas, TX
⁴Janssen Research & Development, LLC, Horsham, PA
⁵Sierra Medical Affairs, LLC, Truckee, CA

Adeel M Khan, MD, MS, MPH^1,2, Zimu Gong, MD, PhD³, Tanushree Prasad, MS^4*, Rahul Banerjee, MD, FACP⁵, Srija Shankar, MBBS^1*, Aimaz Afrough, MD⁶, Larry D Anderson Jr., MD, PhD⁷, Meera Mohan, MD⁸ and Gurbakhash Kaur, MD, MA¹

¹Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX
²Peter O'Donnell Jr School of Public Health, University of Texas Southwestern Medical Center, Dallas, TX
³University of Oklahoma Heath Sciences Center, Houston, TX
⁴Biostatistics and Data Science Core, University of Texas Southwestern Medical Center, Dallas, TX
⁵University of Washington, Fred Hutchinson Cancer Center, Seattle, WA
⁶Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Coppell, TX
⁷Harold C. Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, TX
⁸Division of Hematology and Oncology, Medical College of Wisconsin, Milwaukee, WI